Sublethal enteroviral infection exacerbates disease progression in an ALS mouse model.
Yuan Chao XueHuitao LiuYasir MohamudAmirhossein BahreyniJingchun ZhangNeil R CashmanHonglin LuoPublished in: Journal of neuroinflammation (2022)
Our study identifies a new risk factor that contributes to early onset and accelerated progression of ALS and offers opportunities for the development of novel targeted therapies.